Price-Fixing Conspiracy Securities Fraud Claims Trimmed From Stock-Drop Suit
PHILADELPHIA — A federal judge in Pennsylvania on Feb. 14 ruled that a lead plaintiff in a securities class action lawsuit against a generic drug company and certain of its current...To view the full article, register now.
Already a subscriber? Click here to view full article